Abstract:Abstract Background Dilated cardiomyopathy (DCM) is a major cause of heart failure and sudden cardiac death. As DCM is a genetically heterogeneous disease, genetic variants of cardiac transcription factor genes may play an important role. Transcription factor TBX20, an indispensable factor in normal heart development, is involved in the regulation of cardiac structure and function. Although the TBX20 gene is associated with the occurrence and development of DCM, the influence of genetic variants of the TBX20 gene promoter region on DCM has not been reported. Methods We conducted a case–control study consisting of 107 DCM patients and 210 healthy controls. Genetic variants within TBX20 gene promoter region were identified using sequencing techniques and were functionally analyzed by dual‐luciferase reporting assay. Electrophoretic mobility shift assay (EMSA) was used to investigate DNA‐protein interactions. Results In this study cohort ( n = 317), we identified eight variants within TBX20 gene promoter. One novel DNA sequence variants (DSV) (g.4275G>T) and four single‐nucleotide polymorphisms (SNPs) [g.4169G>A (rs1263874255), g.4949C>T (rs1191745927), g.5114G>A (rs112076877), g.5252C>T (rs1356932911)] were identified in DCM patients, but in none of controls. Among them, the DSV (g.4275G>T) and three SNPs [g.4949C>T (rs1191745927), g.5114G>A (rs112076877) and g.5252C>T (rs1356932911)] significantly altered the transcription activity of TBX20 gene promoter by dual‐luciferase reporting assay ( p T) and three SNPs [g.4949C>T (rs1191745927), g.5114G>A (rs112076877) and g.5252C>T (rs1356932911)] affected the binding of transcription factors. Conclusions These data indicate that the DSV (g.4275G>T) and three SNPs [g.4949C>T (rs1191745927), g.5114G>A (rs112076877) and g.5252C>T (rs1356932911)] increase transcription activity of TBX20 gene promoter in both HEK‐293 and neonatal rat cardiomyocytes (NRCMs) cell lines by affecting the binding of transcription factors. But the mechanism remains to be verified in vivo.

TBX20 Loss-of-function Mutation Associated with Familial Dilated Cardiomyopathy.

TBX5 Loss-of-function Mutation Contributes to Familial Dilated Cardiomyopathy

A Novel Tbx20 Loss-Of-Function Mutation Contributes to Adult-Onset Dilated Cardiomyopathy or Congenital Atrial Septal Defect

ZBTB17 Loss-of-function Mutation Contributes to Familial Dilated Cardiomyopathy

Analysis of the mutational spectrum of TBX20 associated with sporadic dilated cardiomyopathy

A Novel GATA4 Loss-of-function Mutation Responsible for Familial Dilated Cardiomyopathy

Association Between SCN5A R225Q Variant and Dilated Cardiomyopathy: Potential Role of Intracellular Ph and WNT/β-catenin Pathway

Genetic and functional variants of the TBX20 gene promoter in dilated cardiomyopathy

GATA5 Loss-of-function Mutation in Familial Dilated Cardiomyopathy.

The Novel Mitochondrial 16S Rrna 2336T>C Mutation is Associated with Hypertrophic Cardiomyopathy

GATA4 Loss-of-function Mutation Underlies Familial Dilated Cardiomyopathy.

MEF2C loss-of-function mutation associated with familial dilated cardiomyopathy.

Identification and Functional Prediction of Long Non-Coding RNAs in Dilated Cardiomyopathy by Bioinformatics Analysis

A Novel Nkx2-5 Loss-Of-Function Mutation Predisposes to Familial Dilated Cardiomyopathy and Arrhythmias

VEZF1 Loss-of-function Mutation Underlying Familial Dilated Cardiomyopathy.

Gata6 Loss-Of-Function Mutations Contribute To Familial Dilated Cardiomyopathy

HAND1 loss-of-function mutation associated with familial dilated cardiomyopathy.

Identification and Functional Characterization of KLF5 As a Novel Disease Gene Responsible for Familial Dilated Cardiomyopathy.

Detection and functional characterization of a novel <i>MEF2A</i> variation responsible for familial dilated cardiomyopathy

CASZ1 Loss-of-function Mutation Contributes to Familial Dilated Cardiomyopathy

Prevalence and spectrum of GATA4 mutations associated with sporadic dilated cardiomyopathy.